Does polycystic ovary syndrome affect morphokinetics or abnormalities in early embryonic development?

Area of Science:

• Reproductive endocrinology and infertility
• Embryology and developmental biology
• Genetics and genomics

Background:

• Polycystic ovary syndrome (PCOS) is a common endocrine disorder affecting reproductive-aged women.
• Oocyte quality and early embryonic development are crucial for successful conception and implantation.
• Time-lapse imaging (TLI) offers continuous monitoring of embryonic development.

Purpose of the Study:

• To evaluate the effect of oocyte retrieval in PCOS patients on early embryonic development.
• To compare morphokinetics and abnormality incidence in embryos from PCOS and non-PCOS women using TLI.
• To determine if PCOS influences key embryonic developmental milestones.

Main Methods:

• Prospective study comparing 39 PCOS patients with 67 controls undergoing ICSI.
• Controlled ovarian stimulation using a GnRH antagonist protocol.
• Time-lapse monitoring of 402 PCOS zygotes and 449 control zygotes for 48 hours post-injection.

Main Results:

• PCOS patients yielded more oocytes and MII oocytes per cycle.
• No significant differences in oocyte maturation rate or embryo morphology quality.
• Embryonic development timepoints (2-cell to 6-cell stage) were similar; however, the 'optimal' t2 stage timing was reduced in the PCOS group (37.8% vs 48.1%).
• Incidence of abnormal fertility, multinucleation, direct, and reverse cleavage did not differ significantly.

Conclusions:

• PCOS does not adversely affect the morphokinetics of early embryonic development.
• The incidence of common embryonic abnormalities is not increased in women with PCOS.
• TLI analysis supports that PCOS itself does not impair fundamental early embryo development processes.